Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen B Duffull

Showing results (111-120 of 172) with videos related to

Pageof 18
Sort By:
Exploratory Research in Clinical and Social Pharmacy|July 6, 2023
What do pharmacy users think of free pharmacy services? Investigating pharmacy users' perceptions, attitudes and willingness to pay for free healthcare from pharmaciesYasmin H Abdul Aziz, Susan J Heydon, Stephen B Duffull, et al.
International Journal of Emergency Medicine|April 23, 2009
Assessing risk of a prolonged QT interval-a survey of emergency physiciansAmanda S Y Chan, Geoffrey K Isbister, Carl M J Kirkpatrick, et al.
European Journal of Clinical Pharmacology|July 29, 2005
Population pharmacokinetics of mycophenolic acid during the first week after renal transplantationChristine E Staatz, Stephen B Duffull, Bryce Kiberd, et al.
British Journal of Pharmacology|June 5, 2023
A kinetic model for positive allosteric modulator (PAM)-antagonists for the type 1 cannabinoid (CBLiang Yang, Xiao Zhu, David B Finlay, et al.
Malaria Journal|November 15, 2013
A robust design for identification of the Parasite Clearance EstimatorKris M Jamsen, Stephen B Duffull, Joel Tarning, et al.
Clinical Toxicology (Philadelphia, Pa.)|November 19, 2011
Methanol and ethylene glycol acute poisonings - predictors of mortalityCarolyn V Coulter, Sarah E Farquhar, Claire M McSherry, et al.
Basic & Clinical Pharmacology & Toxicology|July 8, 2011
The influence of dosing time, variable compliance and circadian low-density lipoprotein production on the effect of simvastatin: simulations from a pharmacokinetic-pharmacodynamic modelDaniel F B Wright, Venkata V Pavan Kumar, Hesham S Al-Sallami, et al.
Antimicrobial Agents and Chemotherapy|October 21, 2015
Pharmacokinetic-Pharmacodynamic Model for the Effect of l-Arginine on Endothelial Function in Patients with Moderately Severe Falciparum MalariaJanneke M Brussee, Tsin W Yeo, Daniel A Lampah, et al.
CPT: Pharmacometrics & Systems Pharmacology|June 27, 2025
A Pharmacometric Workflow for Resolving Model Instability in Model Use-Reuse SettingsStephen B Duffull, Daniel F B Wright, Xiao Zhu, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|January 16, 2024
Insight into the mechanism of action of ORG27569 at the cannabinoid type one receptor utilising a unified mathematical modelHayley M Green, Liang Yang, Xiao Zhu, et al.
Pageof 18

Showing results (111-120 of 172) with videos related to

Sort By:
Pageof 18
Exploratory Research in Clinical and Social Pharmacy|July 6, 2023
What do pharmacy users think of free pharmacy services? Investigating pharmacy users' perceptions, attitudes and willingness to pay for free healthcare from pharmaciesYasmin H Abdul Aziz, Susan J Heydon, Stephen B Duffull, et al.
International Journal of Emergency Medicine|April 23, 2009
Assessing risk of a prolonged QT interval-a survey of emergency physiciansAmanda S Y Chan, Geoffrey K Isbister, Carl M J Kirkpatrick, et al.
European Journal of Clinical Pharmacology|July 29, 2005
Population pharmacokinetics of mycophenolic acid during the first week after renal transplantationChristine E Staatz, Stephen B Duffull, Bryce Kiberd, et al.
British Journal of Pharmacology|June 5, 2023
A kinetic model for positive allosteric modulator (PAM)-antagonists for the type 1 cannabinoid (CBLiang Yang, Xiao Zhu, David B Finlay, et al.
Malaria Journal|November 15, 2013
A robust design for identification of the Parasite Clearance EstimatorKris M Jamsen, Stephen B Duffull, Joel Tarning, et al.
Clinical Toxicology (Philadelphia, Pa.)|November 19, 2011
Methanol and ethylene glycol acute poisonings - predictors of mortalityCarolyn V Coulter, Sarah E Farquhar, Claire M McSherry, et al.
Basic & Clinical Pharmacology & Toxicology|July 8, 2011
The influence of dosing time, variable compliance and circadian low-density lipoprotein production on the effect of simvastatin: simulations from a pharmacokinetic-pharmacodynamic modelDaniel F B Wright, Venkata V Pavan Kumar, Hesham S Al-Sallami, et al.
Antimicrobial Agents and Chemotherapy|October 21, 2015
Pharmacokinetic-Pharmacodynamic Model for the Effect of l-Arginine on Endothelial Function in Patients with Moderately Severe Falciparum MalariaJanneke M Brussee, Tsin W Yeo, Daniel A Lampah, et al.
CPT: Pharmacometrics & Systems Pharmacology|June 27, 2025
A Pharmacometric Workflow for Resolving Model Instability in Model Use-Reuse SettingsStephen B Duffull, Daniel F B Wright, Xiao Zhu, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|January 16, 2024
Insight into the mechanism of action of ORG27569 at the cannabinoid type one receptor utilising a unified mathematical modelHayley M Green, Liang Yang, Xiao Zhu, et al.
Pageof 18